期刊
LEUKEMIA & LYMPHOMA
卷 54, 期 12, 页码 2685-2692出版社
TAYLOR & FRANCIS LTD
DOI: 10.3109/10428194.2013.781168
关键词
Nelfinavir; autophagy; ER stress; drug screening; chronic lymphocytic leukemia
资金
- Leukemia and Lymphoma Society Specialized Center of Research
- D. Warren Brown Foundation
- National Cancer Institute [K12CA133250]
- NIH NRSA T32 Oncology Training Grant
The endoplasmic reticulum (ER) plays a vital function in multiple cellular processes. There is a growing interest in developing therapeutic agents that can target the ER in cancer cells, inducing a stress response that leads to cell death. However, ER stress-inducing agents can also induce autophagy, a survival strategy of cancer cells. Therefore, by inhibiting autophagy we can increase the efficacy of the ER stress-inducing agents. Nelfinavir, a human immunodeficiency virus (HIV) protease inhibitor with anti-cancer properties, can induce ER stress. Nelfinavir's effects on chronic lymphocytic leukemia (CLL) are yet to be elucidated. Herein we demonstrate that nelfinavir induces ER morphological changes and stress response, along with an autophagic protective strategy. Our data reveal that chloroquine, an autophagy inhibitor, significantly increases nelfinavir cytotoxicity. These results identify a novel strategy potentially effective in CLL treatment, by repositioning two well-known drugs as a combinatorial therapy with anti-cancer properties.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据